MEDTEQ and BioAlberta strengthen ties to accelerate and enhance national collaborations in the medical technologies’ ecosystem

Montreal, October 15, 2019 – The Industrial Consortium for Innovation in Medical Technologies, MEDTEQ (Canada and Quebec), and BioAlberta (Alberta) are proud to announce the signature of a partnership aiming to foster the national and international collaborations in the Canadian medical technologies. This agreement aims to facilitate the structuring of collaborations and funding opportunities for collaborative projects and innovative medtech companies.

Increased collaboration between Canadian regions

This partnership will strengthen project and funding opportunities for Alberta companies in the MEDTEQ Canadian network through its many innovation support and financing tools. Conversely, Canadian companies will benefit from new collaboration and financing opportunities in Alberta. By extension, international companies in the MEDTEQ network will also be able to take advantage of these increased opportunities.

This partnership will allow for greater cooperation between the two organizations, allowing them to better combine their resources and services: grants for collaborative projects, adoption of new technologies and investments in young companies.

“This partnership is a continuation of our efforts over the past year to strengthen and promote collaborative projects that can support the growth of Canadian SME. BioAlberta is a dynamic cluster with which we are pleased to work, and we are convinced that our respective members will benefit from our synergy,” said Diane Côté, President and CEO of MEDTEQ.

“We are pleased to formalize our collaboration with MEDTEQ to increase opportunities for Alberta medtech companies to access capital.  MEDTEQ’s programs will assist Alberta companies by not only providing additional financing opportunities, it will also lead to collaborative projects with national and international companies that may not have yet discovered Alberta’s flourishing medtech sector,” said Mel Wong, President and CEO of BioAlberta.

-30-


About MEDTEQ

MEDTEQ is the pan-Canadian Consortium for Industrial Research and Innovation in Medical Technology. Its mission is to accelerate the development of innovative technological solutions to improve patients’ health and quality of life. MEDTEQ supports their validation and integration in the healthcare system and their impact, both locally and globally, by bringing together the complementary skills of industrial and academic partners, and with those of healthcare providers. MEDTEQ relies on the financial support of the Government of Quebec, the Government of Canada (delivered through the Centres of Excellence for Commercialization and Research (CECR)), the private sector and complementary partners to foster research-industry relations.

About BioAlberta

BioAlberta is the leading voice and champion for the life sciences in Alberta. The Association’s vision is to create a thriving and competitive life sciences industry to facilitate and accelerate economic diversification, investment attraction and job growth in Alberta. BioAlberta is a private, not-for-profit industry association, representing more than 175 members of Alberta’s steadily growing life sciences industry of researchers, producers and suppliers in the province. These members operate in specialized sectors, such as pharmaceuticals, medical devices, natural health products, as well as environmental, agricultural and industrial biotechnology. BioAlberta’s activities are focused on advocacy, promotion and proactively facilitating the growth of Alberta’s life sciences industry. For more information, go to: www.bioalberta.com.

 

Contact

MEDTEQ
Julien Caudroit,
Communications Director
514 398-0896 ext 2405
julien.caudroit@medteq.ca